- Promote the creation of a new model case by providing support for spin-out ventures from the establishment stage in order to contribute to the development of early stage seeds from domestic pharmaceutical companies
- Aim to promote open innovation by mobilizing resources and technological research in the pharmaceutical industry
- Contribute towards solving societal issues by providing innovative pharmaceutical products for intractable diseases with high unmet medical needs
Our Portfolio
Curadim Pharma Co., Ltd.
Outline | R&D of pharmaceutical products |
---|---|
Website | |
Industry | Health/medicine |
Commercialization stage | Early stage |
Provided Support
Authorized Investment | 1 billion yen (maximum) |
---|---|
Announcement Date | Aug 04, 2016 |
Investment Structure |